Genomic profiling of metastatic breast cancer identifies the Hippo pathway to be a key determinant of CDK4/6 inhibitor sensitivity Meeting Abstract

  

Authors:	Razavi, P.; Li, Q.; Li, Z.; Brown, D. N.; Ping, C.; Shen, R.; Sanchez-Vega, F.; Schultz, N. D.; Baselga, J.; Scaltriti, M.; Reis-Filho, J. S.; Chandarlapaty, S.
Abstract Title:	Genomic profiling of metastatic breast cancer identifies the Hippo pathway to be a key determinant of CDK4/6 inhibitor sensitivity
Meeting Title:	110th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title:	Cancer Research
Volume:	79
Issue:	13 Suppl.
Meeting Dates:	2019 Mar 29-Apr 3
Meeting Location:	Atlanta, GA
ISSN:	0008-5472
Publisher:	American Association for Cancer Research
Date Published:	2019-07-01
Language:	English
ACCESSION:	WOS:000488129903027
DOI:	10.1158/1538-7445.Am2019-927
PROVIDER:	wos
Notes:	Meeting Abstract: 927 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/156080